Bond P A, Cundall R L, Falloon I R
Br J Psychiatry. 1979 Apr;134:360-5. doi: 10.1192/bjp.134.4.360.
Monoamine oxidase (MAO) levels in plasma, platelets, lymphocytes and granulocytes have been compared in schizophrenics and controls using three substrates. No significant difference was found between MAO levels in controls and the schizophrenic group as a whole, but platelets and lymphocytes of the latter (tyramine or benzylamine substrate) showed greater variation and in some cases higher values than controls, irrespective of treatment. Schizophrenics who experienced auditory hallucinations had significantly lower MAO levels in lymphocytes and platelets than those who did not.
使用三种底物对精神分裂症患者和对照组的血浆、血小板、淋巴细胞及粒细胞中的单胺氧化酶(MAO)水平进行了比较。对照组和整个精神分裂症患者组的MAO水平未发现显著差异,但后者(使用酪胺或苄胺底物)的血小板和淋巴细胞显示出更大的变异性,且在某些情况下其值高于对照组,与治疗无关。有幻听的精神分裂症患者的淋巴细胞和血小板中的MAO水平显著低于无幻听的患者。